Cargando…
Renin angiotensin system: A novel target for migraine prophylaxis
Migraine constitutes 16% of primary headaches affecting 10-20% of general population according to International Headache Society. Till now nonsteroidalanti-inflammatory drugs (NSAIDS), opioids and triptans are the drugs being used for acute attack of migraine. Substances with proven efficacy for pre...
Autores principales: | Nandha, Ruchika, Singh, Harpal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326904/ https://www.ncbi.nlm.nih.gov/pubmed/22529467 http://dx.doi.org/10.4103/0253-7613.93840 |
Ejemplares similares
-
Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
por: Abidi, Afroz
Publicado: (2014) -
Endocan: A novel circulating proteoglycan
por: Kali, Arunava, et al.
Publicado: (2014) -
2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2020) -
New insights into molecular targets for urinary incontinence
por: Poonia, Manoj K., et al.
Publicado: (2010) -
Biological agents targeting beyond TNF-alpha
por: Sharma, Rashmi, et al.
Publicado: (2008)